John Stewart Sharman - 24 Feb 2022 Form 4 Insider Report for UNIVERSAL BIOSENSORS INC

Role: Chief Executive Officer
Signature: /s/ John Sharman
Issuer symbol: N/A
Transactions as of: 24 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 28 Feb 2022, 05:08:36 UTC
Previous filing: 14 Sep 2021
Next filing: 31 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	UBI	Common Stock	Award	$0	+30,000		$0.000000	30,000	24 Feb 2022	Direct
holding	UBI	Common Stock						276,217	24 Feb 2022	By wife	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	UBI	Stock Option (Right to Buy)						1,364,666	24 Feb 2022	Common Stock	1,364,666	$0.2000	Direct	F2, F3
holding	UBI	Stock Options (Right to Buy)						1,000,000	24 Feb 2022	Common Stock	1,000,000	$0.2000	By wife	F1, F2, F3
holding	UBI	Performance Rights						2,500,000	24 Feb 2022	Common Stock	2,500,000		Direct	F4
holding	UBI	Performance Rights						1,250,000	24 Feb 2022	Common Stock	1,250,000		Direct	F5
holding	UBI	Stock Options (Right to Buy)						2,364,667	24 Feb 2022	Common Stock	2,364,667	$0.2500	Direct	F2, F3
holding	UBI	Stock Options (Right to Buy)						1,364,667	24 Feb 2022	Common Stock	1,364,667	$0.3000	Direct	F2, F3
holding	UBI	Stock Options (Right to Buy)						1,000,000	24 Feb 2022	Common Stock	1,000,000	$0.3000	By superannuation fund	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person disclaims beneficial ownership of the shares held by his wife, and this report should not be deemed an admission that the reporting person is the beneficial owner of his wife's shares for purposes of Section 16 or for any other purpose.
F2	The price reported is stated in Australian dollars.
F3	The options are fully vested and became exercisable after September 24, 2020.
F4	Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
F5	Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.